Are we adequately considering drug interactions when prescribing statins to patients on cART with dyslipidaemia?

被引：0
|
作者：
Myers, J. [1 ]
Rayment, M. [1 ]
Sonecha, S. [1 ]
Moyle, G. [1 ]
Boffito, M. [1 ]
机构：
[1] Chelsea & Westminster Hosp, NHS Fdn Trust, London, England
来源：
HIV MEDICINE | 2009年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：33 / 34
页数：2
相关论文
共 46 条
  • [31] Possibility of Multiple Drug-Drug Interactions in Patients Treated with Statins: Analysis of Data from the Japanese Adverse Drug Event Report (JADER) Database and Verification by Animal Experiments
    Negishi, Akio
    Oshima, Shinji
    Mutoh, Mizue
    Horii, Norimitsu
    Inoue, Naoko
    Numajiri, Sachihiko
    Ohshima, Shigeru
    Kobayashi, Daisuke
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2022, 19 (12): : 1816 - 1823
  • [32] Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: Are the statins mechanistically similar?
    Christians, U
    Jacobsen, W
    Floren, LC
    PHARMACOLOGY & THERAPEUTICS, 1998, 80 (01) : 1 - 34
  • [33] Should we proceed with more caution when considering additional autologous fertility solutions for some patients with classic Turner syndrome?
    Taggar, Arti A.
    Engmann, Lawrence L.
    FERTILITY AND STERILITY, 2021, 115 (05) : 1173 - 1174
  • [34] A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug–Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy
    Elinor Ben-Menachem
    Boudewijn Gunning
    Carmen María Arenas Cabrera
    Kevan VanLandingham
    Julie Crockett
    David Critchley
    Louise Wray
    Bola Tayo
    Gilmour Morrison
    Manuel Toledo
    CNS Drugs, 2020, 34 : 661 - 672
  • [35] Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease A Scientific Statement From the American Heart Association
    Wiggins, Barbara S.
    Saseen, Joseph J.
    Page, Robert L., II
    Reed, Brent N.
    Sneed, Kevin
    Kostis, John B.
    Lanfear, David
    Virani, Salim
    Morris, Pamela B.
    CIRCULATION, 2016, 134 (21) : E468 - E495
  • [36] Prevalence and predictors of clinically significant statin-drug interactions among Yemeni patients taking statins for primary and secondary prevention of cardiovascular disease
    Al-Ashwal, Fahmi Y.
    Sulaiman, Syed Azhar Syed
    Ghadzi, Siti Maisharah Sheikh
    Kubas, Mohammed Abdullah
    Halboup, Abdulsalam
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (06) : 889 - 899
  • [37] A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy
    Ben-Menachem, Elinor
    Gunning, Boudewijn
    Cabrera, Carmen Maria Arenas
    VanLandingham, Kevan
    Crockett, Julie
    Critchley, David
    Wray, Louise
    Tayo, Bola
    Morrison, Gilmour
    Toledo, Manuel
    CNS DRUGS, 2020, 34 (06) : 661 - 672
  • [38] Correction for potentially inappropriate prescribing can increase specificity when using drug prescriptions as an adjunct to diagnostic codes to assess comorbidities in older patients
    Fiorini, Gianfrancesco
    Castagna, Alberto
    Cerri, Cesare
    Rega, Vincenzo
    Rigamonti, Antonello E.
    Cella, Silvano G.
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2019, 16 (01)
  • [39] The current system for prescribing antiretroviral therapy puts HIV-infected patients at risk of serious drug-drug interactions: is now the time for a paradigm shift in HIV care delivery?
    Whitlock, G. G.
    Patel, A.
    Edwards, S. G.
    Benn, P. D.
    Miller, R. F.
    CLINICAL MEDICINE, 2012, 12 (03) : 300 - 301
  • [40] Medication Use in Patients with Chronic Hepatitis C (HCV) from a US Commercial Claims Database: Inadequacy of Prescribing Information for Assessment of Potential Drug Interactions
    Mayer, Christina L.
    Lauffenburger, Julie C.
    Farley, Joel F.
    Brouwer, Kim
    Fried, Michael W.
    Hawke, Roy L.
    HEPATOLOGY, 2012, 56 : 260A - 261A
12345